📰 Bioaffinity Technologies News
Page 4 - Bioaffinity Technologies News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bioaffinity Technologies. Real-time updates on events, politics, business and more.
May 5, 2023
BioAffinity Technologies, Inc. (NASDAQ:BIAF – Get Rating)’s stock price was down 1% during mid-day trading on Tuesday . The company traded as low as $2.02 and last traded at $2.03. Approximately 8,182 shares traded hands during trading, a decline of 99% from the average daily volume of 983,699 shares. The stock had previously closed at […]
May 1, 2023
BioAffinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage cancer, today announced that Michael Dougherty has joined... | May 1, 2023
May 1, 2023
BioAffinity Technologies today announced it appointed Michael Dougherty as chief financial officer, effective immediately.
April 18, 2023
BioAffinity Technologies (NASDAQ:BIAF – Get Rating) and iSpecimen (NASDAQ:ISPC – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends. Profitability This table compares bioAffinity Technologies and iSpecimen’s net margins, […]
April 1, 2023
31.03.2023 - bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three and 12 months ended ...
March 31, 2023
Conference Call Scheduled for April 3, 2023, at 9:00 a.m. Eastern Time ... | March 31, 2023
March 28, 2023
BioAffinity Technologies, Inc. today announced the publication of a paper titled “Porphyrin-modified beads for use as compensation controls in flow cytometry” in the peer-reviewed... | March 28, 2023
March 24, 2023
Conference Call scheduled on April 3, 2023, at 9 a.m. Eastern time ... | March 24, 2023
December 29, 2022
BioAffinity focuses on the development of noninvasive, early-stage cancer diagnosis and targeted cancer treatment.
December 16, 2022
BioAffinity Technologies, Inc. , a biotechnology company addressing the need for noninvasive diagnosis of early-stage cancer and diseases of the lung, as well as targeted cancer treatment, today... | December 15, 2022